A trio of abstracts presented at ACR Convergence 2024, the annual meeting of the American College of Rheumatology, bear out the benefits of bimekizumab (Bimzelx; UCB Pharma) for use against active ...
It all started with a swollen knee last March. It had been aching for a few days and one evening after a work event it became ...
The American College of Rheumatology (ACR) 2024 Convergence has just concluded, showcasing significant advancements and ...
According to the World Health Organisation (WHO), over 350 million people globally suffer from arthritis, and despite ...
Most patients with rheumatoid arthritis or spondyloarthritis had significant antibody responses to COVID vaccine boosters, whether or not their immunomodulatory medications were held.
More than half the women in the treat-to-target group conceived within 3 months vs a median of 6.5 months for those in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback